We are live on ! Find out more
Clearstead Advisors

Clearstead Advisors Portfolio holdings

AUM $10.6B Turnover 42.91%
1-Year Est. Return 24.87%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
-$353M
Cap. Flow
-$277M
Cap. Flow %
-2.62%
Top 10 Hldgs %
28.93%
Holding
3,754
New
1,518
Increased
1,198
Reduced
637
Closed
93
Avg Time Held Equity + Options
2 years
Top 10 Avg Time Held Equity + Options
3 years
Top 20 Avg Time Held Equity + Options
3 years
Avg Time Held Equity only
2 years
Top 10 Avg Time Held Equity only
3 years
Top 20 Avg Time Held Equity only
3.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.29%
2 Technology 11.98%
3 Industrials 7.46%
4 Financials 5.38%
5 Consumer Discretionary 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AQB icon
3651
AquaBounty Technologies
AQB
$5.66M
$2 ﹤0.01%
1
– –
2024 Q2
8 quarters
FSP icon
3652
Franklin Street Properties
FSP
$40.8M
$2 ﹤0.01%
+2
New +$1
2026 Q2
0 quarters
TEAD icon
3653
Teads Holding Co
TEAD
$41.5M
$2 ﹤0.01%
+2
New +$2
2026 Q2
0 quarters
NXXT
3654
NextNRG Inc
NXXT
$10.1M
– –
0
– –
2026 Q2
0 quarters
SKIN icon
3655
SkinHealth Systems
SKIN
$79.5M
– –
0
– –
2026 Q2
0 quarters
AMZE
3656
DELISTED
AMAZE HOLDINGS INC
AMZE
– –
0
– –
2026 Q1
1 quarter
OPENW icon
3657
Opendoor Technologies Inc Series K Warrants
OPENW
$5.03M
$1 ﹤0.01%
+1
New +$1
2026 Q2
0 quarters
ABCL icon
3658
AbCellera Biologics
ABCL
$3.95B
– –
-26
Closed -$91 –
ABOS icon
3659
Acumen Pharmaceuticals
ABOS
$122M
– –
-60
Closed -$142 –
AGX icon
3660
Argan
AGX
$5.15B
– –
-11
Closed -$5.99K –
AL icon
3661
DELISTED
Air Lease Corp
AL
– –
-242
Closed -$15.7K –
ALZN icon
3662
Alzamend Neuro
ALZN
$6.23M
– –
-10,000
Closed -$10.6K –
ANGL icon
3663
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3B
– –
-10,819
Closed -$311K –
AVDE icon
3664
Avantis International Equity ETF
AVDE
$19.3B
– –
-1,478
Closed -$125K –
BCD icon
3665
abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF
BCD
$446M
– –
-205
Closed -$7.33K –
BHP icon
3666
CALL
BHP
BHP
$216B
– –
-502
Closed -$51.1K –
BKLN icon
3667
Invesco Senior Loan ETF
BKLN
$6.28B
– –
-150
Closed -$3.06K –
BKSY icon
3668
BlackSky Technology
BKSY
$736M
– –
-45
Closed -$1.13K –
CGC icon
3669
Canopy Growth
CGC
$317M
– –
-2
Closed -$2 –
CGCP icon
3670
Capital Group Core Plus Income ETF
CGCP
$8.41B
– –
-2,551
Closed -$57K –
CNXC icon
3671
Concentrix
CNXC
$1.71B
– –
-15
Closed -$411 –
CRVS icon
3672
Corvus Pharmaceuticals
CRVS
$818M
– –
-50
Closed -$732 –
CTLP icon
3673
DELISTED
Cantaloupe
CTLP
– –
-4,000
Closed -$43.2K –
CTRA icon
3674
DELISTED
Coterra Energy
CTRA
– –
-4,771
Closed -$168K –
CUK icon
3675
DELISTED
Carnival PLC
CUK
– –
-125
Closed -$3.22K –

Similar funds

Clearstead Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Clearstead Advisors's Q2 2026 filing shows 1,518 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.

  • Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
  • Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
  • Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
  • Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
  • Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
  • Clearstead Advisors opened 1,518 new positions and closed 93 in Q2 2026.
  • Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.